Mallax is a new pharma company with Swedish origins.
With a combination of acquisitions and collaborations we aim to build a portfolio of established pharmaceuticals and OTC products for customers and patients across Europe.
About Mallax Pharma
Mallax was founded by Anders Larnholt, a pharma executive and entrepreneur, and Impilo, a Swedish investment company focused on healthcare and Nordic based companies. Our aim is to invest significant capital and resources for the right acquisition opportunities in Europe.
Sustainability, medical need, and profitable growth are cornerstones of Mallax’s strategy, and they will define how we operate and build our company. Contact us for more information: